china - International Biopharmaceutical Industry

news

Merck brings former executive back to lead ex-US pharmaceuticals business

Dive Brief: Merck has tapped a former executive, Joseph Romanelli, to run the company's pharmaceutical business in markets outside the U.S. after restructuring its...

25 April 2022 news Business | china

Continue Reading →

news

Why the FDA is making a test case of a cancer drug from China

At a quick glance, the Food and Drug Administration's decision to ask its advisers for help in vetting yet another cancer immunotherapy may seem odd. After all, the ...

10 February 2022 news cancer | china

Continue Reading →

news

Merck’s Keytruda gets approval in China for advanced melanoma

Melanoma is one of the fastest growing malignant cancers in China, increasing at an annual rate of 3-5 percent, which makes it one of the deadliest diseases in the co...

31 July 2018 news advanced | approval

Continue Reading →

news

Innovent receives IND approval to initiate Clinical Trials in China

Innovent’s IBI101, is the first OX40-targeted molecule to receive IND approval in China Innovent Biologics, a world-class China-based biopharmaceutical company tha...

27 July 2018 news approval | china

Continue Reading →

news

Nuance enters $58 M deal for non-opioid pain treatment in China

EXPAREL is a non-opioid option for achieving long-lasting pain control after surgery via infiltration into the surgical site or administration as an interscalene brac...

22 June 2018 news $58M | china

Continue Reading →

news

Suven Life Sciences gets patents in China and US

These patents add to the similar protections won in countries such as India, Korea, Singapore, Canada, Japan and Australia in the past. Suven Life Sciences said it ...

15 June 2018 news china | life

Continue Reading →